DLBCL refers to Diffuse Large B-Cell Lymphoma, which is a type of aggressive non-Hodgkin lymphoma that originates in the B-cells of the immune system. Research in this area aims to better understand the biology, causes, and treatment options for DLBCL. This includes studying genetic mutations that may drive the development of DLBCL, identifying biomarkers for early detection, and testing new targeted therapies and immunotherapies. Overall, the goal of research in DLBCL is to improve outcomes and quality of life for patients with this type of cancer.